CMV as an exacerbating agent in transplant vascular sclerosis: potential immune-mediated mechanisms modelled in vitro.
Waldman
W J
WJ
Department of Pathology, Ohio State University College of Medicine, Columbus 43210-1238, USA.
Adams
P W
PW
Knight
D A
DA
Sedmak
D D
DD
D000328:Adult; D001161:Arteriosclerosis / Q000209:etiology / Q000276:immunology*; D002478:Cells, Cultured; D003587:Cytomegalovirus / Q000502:physiology*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000276:immunology; D004730:Endothelium, Vascular / Q000276:immunology / Q000821:virology*; D005260:Female; D006684:HLA-DR Antigens / Q000096:biosynthesis; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000096:biosynthesis; D008297:Male; D011183:Postoperative Complications; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014184:Transplantation, Homologous / Q000276:immunology*
D006684:HLA-DR Antigens; D018799:Intercellular Adhesion Molecule-1